Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsTerminated
NCT02401035Phase 4Updated Apr 9, 2024
Sponsor: Pfizer
Gastroesophageal Reflux Disease
United States, Argentina, Bosnia and Herzegovina, Georgia, Germany +4 more
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)Terminated
NCT03472560Phase 2Updated Apr 9, 2024
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Urothelial Cancer
United States, Hungary, Italy, Poland, Russia +3 more
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy ParticipantsCompleted
NCT05431153Phase 1Updated Apr 8, 2024
Sponsor: Pfizer
Healthy
United States
Study to Evaluate Clinical Real World Outcomes of Lorlatinib After Alectinib in ALK-Positive NSCLC Japanese PatientsCompleted
NCT04979988N/AUpdated Apr 5, 2024
Sponsor: Pfizer
ALK-positive Non-small-cell Lung Cancer
Japan
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate CancerCompleted
NCT03148795Phase 2Updated Apr 5, 2024
Sponsor: Pfizer
Prostate Cancer
United States, Australia, Austria, Belgium, Brazil +9 more
Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating MutationsCompleted
NCT04511533Phase 4Updated Apr 5, 2024
Sponsor: Pfizer
Metastatic Non Small Cell Lung Cancer
India
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)Completed
NCT01942135Phase 3Updated Apr 4, 2024
Sponsor: Pfizer
Metastatic Breast Cancer
United States, Australia, Belgium, Canada, Germany +12 more
Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)Completed
NCT04018001N/AUpdated Apr 3, 2024
Sponsor: Pfizer
Rheumatoid Arthritis
United States
A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803Completed
NCT05286281Phase 1Updated Mar 29, 2024
Sponsor: Pfizer
Healthy
United States
PF-07321332/Ritonavir and Ritonavir on Dabigatran Study in Healthy ParticipantsCompleted
NCT05064800Phase 1Updated Mar 29, 2024
Sponsor: Pfizer
Healthy Participants
United States
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in MoroccoWithdrawn
NCT05997485N/AUpdated Mar 28, 2024
Sponsor: Pfizer
COVID-19 Drug Treatment
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)Completed
NCT02603432Phase 3Updated Mar 27, 2024
Sponsor: Pfizer
Urothelial Cancer
United States, Argentina, Australia, Belgium, Brazil +24 more
Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple CountriesCompleted
NCT04198571N/AUpdated Mar 26, 2024
Sponsor: Pfizer
Community Acquired Pneumonia · Complicated Skin and Soft Tissue Infection
Brazil, Colombia, France, Greece, Italy +2 more
Evaluation of Pharmacokinetics, Safety, and Tolerability of Ceftazidime-avibactam in Neonates and Infants.Terminated
NCT04126031Phase 2Updated Mar 26, 2024
Sponsor: Pfizer
Gram-negative Bacterial Infection
United States, Estonia, Greece, Hungary, India +3 more
A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy InfantsTerminated
NCT04645966Phase 2Updated Mar 25, 2024
Sponsor: Pfizer
Meningococcal Vaccine
Germany, Greece, Spain
Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast CancerCompleted
NCT04134884Phase 1Updated Mar 22, 2024
Sponsor: Kathy Miller
Metastatic Breast Cancer · Triple Negative Breast Cancer · Hormone Receptor Positive Tumor
United States
PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studYUnknown
NCT03423199Phase 3Updated Mar 22, 2024
Sponsor: National Cancer Center, Japan
Breast Neoplasms
Japan, Singapore, South Korea, Taiwan
Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy ParticipantsCompleted
NCT05107492Phase 1Updated Mar 21, 2024
Sponsor: Pfizer
Inflammatory Bowel Disease
China
STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENTCompleted
NCT04604496Phase 1Updated Mar 21, 2024
Sponsor: Pfizer
Hepatic Impairment · Healthy Volunteers
United States
Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast CancerCompleted
NCT03007979Phase 2Updated Mar 20, 2024
Sponsor: Washington University School of Medicine
Breast Cancer · Breast Carcinoma · Cancer of Breast · Malignant Tumor of Breast
United States
Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult PatientsTerminated
NCT04793399Phase 1, Phase 2Updated Mar 19, 2024
Sponsor: Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica
Chronic Phase-Chronic Myeloid Leukemia
Spain
Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of AgeCompleted
NCT04819113Phase 3Updated Mar 18, 2024
Sponsor: Pfizer
Meningococcal Vaccine
Finland, Poland, Spain
A Study to Learn About Bivalent COVID-19 RNA Vaccine Candidate(s) in Healthy Infants and ChildrenWithdrawn
NCT05630352Phase 1Updated Mar 18, 2024
Sponsor: BioNTech SE
COVID-19
A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy AdultsCompleted
NCT05349864Phase 1Updated Mar 15, 2024
Sponsor: Pfizer
Healthy Participants
United States
Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal InfectionCompleted
NCT04927312Phase 3Updated Mar 13, 2024
Sponsor: Pfizer
Complicated Intra-abdominal Infection
Japan

Previous page Next page